Maccura Biotechnology Co (SZSE:300463) Accounts Payable & Accrued Expense : ¥551 Mil (As of Mar. 2025)

View and export this data going back to 2015. Start your Free Trial

What is Maccura Biotechnology Co Accounts Payable & Accrued Expense?

Maccura Biotechnology Co's quarterly accounts payable & accrued expense increased from Sep. 2024 (¥547 Mil) to Dec. 2024 (¥646 Mil) but then declined from Dec. 2024 (¥646 Mil) to Mar. 2025 (¥551 Mil).

Maccura Biotechnology Co's annual accounts payable & accrued expense declined from Dec. 2022 (¥598 Mil) to Dec. 2023 (¥549 Mil) but then increased from Dec. 2023 (¥549 Mil) to Dec. 2024 (¥646 Mil).

Maccura Biotechnology Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Maccura Biotechnology Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Maccura Biotechnology Co Accounts Payable & Accrued Expense Chart

Maccura Biotechnology Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

706.52

551.15

597.99

548.57

645.51

Maccura Biotechnology Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															398.11	485.52	546.79	645.51	550.85

Maccura Biotechnology Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Maccura Biotechnology Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Maccura Biotechnology Co Ltd (SZSE:300463) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Number 8, 2nd Anhe Road, Hi-tech Zone, Chengdu, CHN, 611731

Website

https://www.maccura.com/

Maccura Biotechnology Co Ltd is a China-based in-vitro diagnostic (IVD) integration company engaged in the research and development, production and sales of IVD products. It is also engaged in the sales of foreign brands of in vitro diagnostic products as an agent. The company's developed product and technology development platforms cover clinical biochemistry, chemiluminescent immunoassay, rapid diagnosis, thrombosis, hemostasis, and molecular diagnosis.

Executives

Guo Lei	Director
Wang Deng Ming	Directors, executives
Wang Lin	Supervisors
Wu Ming Jian	Directors, executives
Shi Wei	Directors, executives
Yang Hui	Supervisors
Zhou Yue Guo	Executives
Wang Zhen	Executives
Yu Ping	Executives
Zou Yuan	Supervisors
Xu Sheng Guo	Directors, executives
Liu Qi Lin	Directors, executives
Chu Jian Jun	Executives
Tang Yong	Director
Xu Jin Song	Executives

Maccura Biotechnology Co Headlines

No Headlines